Treace Medical Concepts (TMCI) Asset Writedowns and Impairment (2020 - 2025)
Treace Medical Concepts (TMCI) reported Asset Writedowns and Impairment of -$69000.0 for Q3 2025, down 139.66% on a YoY basis from $174000.0 in Q3 2024, and down 185.19% quarter-over-quarter from $81000.0 in Q2 2025.
Treace Medical Concepts (TMCI) Asset Writedowns and Impairment (2020 - 2025) Analysis & Trends
Treace Medical Concepts has reported Asset Writedowns and Impairment for 6 years, with the latest figure at -$69000.0 in Q3 2025.
- For the quarter ending Q3 2025, Asset Writedowns and Impairment fell 139.66% year-over-year to -$69000.0; the trailing twelve-month figure through Sep 2025 stood at $1.0 million (down 61.84% YoY), and the FY2024 full-year result was $2.9 million, up 625.0% from the prior year.
- Asset Writedowns and Impairment for Q3 2025 stood at -$69000.0, down from $81000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $2.0 million in Q2 2024, with the low at -$227000.0 in Q2 2022.
- Historically, Asset Writedowns and Impairment has averaged $236294.1 across 5 years, with a median of $81000.0 in 2025.
- Annual changes were most pronounced in 2021 — Asset Writedowns and Impairment tumbled 1218.75% — and 2024, when it soared 17300.0%.
- Treace Medical Concepts' Asset Writedowns and Impairment stood at -$179000.0 in 2021, then soared by 350.84% to $449000.0 in 2022, then fell by 28.51% to $321000.0 in 2023, then jumped by 61.68% to $519000.0 in 2024, then sank by 113.29% to -$69000.0 in 2025.
- The last three Asset Writedowns and Impairment figures came in at -$69000.0 (Q3 2025), $81000.0 (Q2 2025), and $500000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Treace Medical Concepts | 274.20 Mn | 222.34 Mn | 37.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -69,000.00 |
| Sep 30, 2025 | -69,000.00 |
| Jun 30, 2025 | 81,000.00 |
| Jun 30, 2025 | 81,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Dec 31, 2024 | 519,000.00 |
| Dec 31, 2024 | 519,000.00 |
| Sep 30, 2024 | 174,000.00 |
| Sep 30, 2024 | 174,000.00 |
| Jun 30, 2024 | 2.05 Mn |
| Jun 30, 2024 | 2.05 Mn |
| Mar 31, 2024 | 159,000.00 |
| Mar 31, 2024 | 159,000.00 |
| Dec 31, 2023 | 321,000.00 |
| Dec 31, 2023 | 321,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 40,000.00 |
| Jun 30, 2023 | 40,000.00 |